Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 862189-96-6
2. Mirodenafil (dihydrochloride)
3. Nl7l8twt8y
4. Mirodenafil Hydrochloride
5. Unii-nl7l8twt8y
6. Mvix
7. Sk 3530
8. 862189-96-6 (hcl)
9. Sk-3530
10. 5-ethyl-2-[5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-2-propoxyphenyl]-7-propyl-3h-pyrrolo[3,2-d]pyrimidin-4-one;dihydrochloride
11. 5-ethyl-2-(5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)-2-propoxyphenyl)-7-propyl-3,5-dihydro-4h-pyrrolo[3,2-d]pyrimidin-4-one Dihydrochloride
12. 5-ethyl-2-(5-(4-(2-hydroxyethyl)piperazine-1-sulfonyl)-2-propoxyphenyl)-7-propyl-3,5-dihydropyrrolo(3,2-d)pyrimidin-4-one
13. 5-ethyl-2-(5-{[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl}-2-propoxyphenyl)-7-propyl-3h,4h,5h-pyrrolo[3,2-d]pyrimidin-4-one Dihydrochloride
14. 5-ethyl-2-[5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-2-propoxyphenyl]-7-propyl-1h-pyrrolo[3,2-d]pyrimidin-4-one Dihydrochloride
15. Sk-3530 Dihydrochloride
16. M-vix
17. Schembl22028340
18. Hy-14930a
19. Cs-3125
20. Mirodenafil Hydrochloride [who-dd]
21. Ms-30654
22. F85032
23. Sk-3530 Dihydrochloridesk-3530 Dihydrochloride
24. A914997
25. 1-piperazineethanol, 4-((3-(5-ethyl-4,5-dihydro-4-oxo-7-propyl-1h-pyrrolo(3,2-d)pyrimidin-2-yl)-4-propoxyphenyl)sulfonyl)-, Dihydrochloride
26. 4h-pyrrolo(3,2-d)pyrimidin-4-one, 5-ethyl-3,5-dihydro-2-(5-((4-(2-hydroxyethyl)-1-piperazinyl)sulfonyl)-2-propoxyphenyl)-7-propyl-, Hydrochloride (1:2)
27. 5-ethyl-2-(5-{[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl}-2-propo Xyphenyl)-7-propyl-3,5-dihydro-4h-pyrrolo[3,2-d]pyrimidin-4-one D Ihydrochloride
28. 5-ethyl-3,5-dihydro-2-(5-((4-(2-hydroxyethyl)-1-piperazinyl)sulfonyl)-2-propoxyphenyl)-7-propyl-4h-pyrrolo(3,2-d)pyrimidin-4-one Hydrochloride (1:2)
| Molecular Weight | 604.6 g/mol |
|---|---|
| Molecular Formula | C26H39Cl2N5O5S |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 11 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 125 |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 902 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
ABOUT THIS PAGE
25
PharmaCompass offers a list of Mirodenafil dihydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mirodenafil dihydrochloride manufacturer or Mirodenafil dihydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mirodenafil dihydrochloride manufacturer or Mirodenafil dihydrochloride supplier.
PharmaCompass also assists you with knowing the Mirodenafil dihydrochloride API Price utilized in the formulation of products. Mirodenafil dihydrochloride API Price is not always fixed or binding as the Mirodenafil dihydrochloride Price is obtained through a variety of data sources. The Mirodenafil dihydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mirodenafil dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mirodenafil dihydrochloride, including repackagers and relabelers. The FDA regulates Mirodenafil dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mirodenafil dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mirodenafil dihydrochloride supplier is an individual or a company that provides Mirodenafil dihydrochloride active pharmaceutical ingredient (API) or Mirodenafil dihydrochloride finished formulations upon request. The Mirodenafil dihydrochloride suppliers may include Mirodenafil dihydrochloride API manufacturers, exporters, distributors and traders.
Mirodenafil dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mirodenafil dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mirodenafil dihydrochloride GMP manufacturer or Mirodenafil dihydrochloride GMP API supplier for your needs.
A Mirodenafil dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Mirodenafil dihydrochloride's compliance with Mirodenafil dihydrochloride specifications and serves as a tool for batch-level quality control.
Mirodenafil dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Mirodenafil dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mirodenafil dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Mirodenafil dihydrochloride EP), Mirodenafil dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mirodenafil dihydrochloride USP).
